Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.915
+0.035 (3.99%)
Dec 20, 2024, 4:00 PM EST - Market closed
Cytosorbents Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 50 | 58 | 68 | 182 | 344 | 125 | |
| Market Cap Growth | -2.11% | -14.31% | -62.87% | -47.06% | 175.66% | -51.19% | |
| Enterprise Value | 71 | 68 | 58 | 135 | 272 | 125 | |
| Last Close Price | 0.92 | 1.11 | 1.55 | 4.19 | 7.97 | 3.85 | |
| PS Ratio | 1.27 | 1.59 | 1.95 | 4.22 | 8.39 | 5.00 | |
| PB Ratio | 3.84 | 2.49 | 1.91 | 2.91 | 4.34 | 36.52 | |
| P/TBV Ratio | 6.28 | 2.99 | 2.18 | 3.15 | 4.59 | 2204.33 | |
| EV/Sales Ratio | 1.89 | 1.86 | 1.69 | 3.12 | 6.64 | 5.01 | |
| Debt / Equity Ratio | 2.06 | 0.79 | 0.52 | 0.22 | 0.01 | 4.72 | |
| Asset Turnover | 0.79 | 0.62 | 0.45 | 0.48 | 0.70 | 0.81 | |
| Inventory Turnover | 4.52 | 3.91 | 3.39 | 2.97 | 4.62 | 5.00 | |
| Quick Ratio | 1.46 | 1.39 | 2.86 | 4.14 | 7.54 | 1.68 | |
| Current Ratio | 1.97 | 1.77 | 3.48 | 4.70 | 8.12 | 2.10 | |
| Return on Equity (ROE) | -118.50% | -97.21% | -67.00% | -34.64% | -18.97% | -189.32% | |
| Return on Assets (ROA) | -27.93% | -32.48% | -25.27% | -15.84% | -11.05% | -38.52% | |
| Return on Capital (ROIC) | -34.88% | -39.74% | -29.69% | -18.15% | -12.99% | -49.55% | |
| Earnings Yield | -37.32% | -49.19% | -48.51% | -13.48% | -2.28% | -15.43% | |
| FCF Yield | -37.58% | -38.29% | -50.75% | -9.69% | -1.84% | -13.98% | |
| Buyback Yield / Dilution | -19.27% | -2.49% | -0.49% | -11.70% | -20.35% | -5.00% | |
| Total Shareholder Return | -19.27% | -2.49% | -0.49% | -11.70% | -20.35% | -5.00% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.